Tocagen

Developer of gene therapies for the treatment of cancer

placeSan Diego, California, United States calendar_todayFounded 2007 groups1 employees language tocagen.com

Registered entities

Innovation

20 patent families (13 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 2,921 times.

YearFilings
20127
20137
20148
20158
20169
201712
20189
20198
20208
20212

Investor mix

13 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital431%
Private equity323%
Other / undisclosed646%
Coming soon